Colorado Overdose Deaths Defy National Trend, Rising 13% in 2025

America's overdose crisis is showing signs of retreat. For the third consecutive year, fatal drug overdoses declined across the United States, with preliminary CDC data showing a 15% drop in 2025 that brought national death totals back to 2019 levels. Roughly 70,000 people died from overdoses last year—still a staggering figure, but one that represents meaningful progress in a battle that has claimed more than a million lives over two decades.

Yet this national narrative masks a troubling regional divergence. While coastal states and much of the Midwest saw significant improvements, a cluster of Western states moved in the opposite direction. Colorado led this concerning trend, with overdose deaths rising 13% from 1,603 in 2024 to 1,813 in 2025, according to preliminary data from the Colorado Department of Public Health and Environment.

The Denver Spike

Within Colorado's largest city, the situation grew particularly dire during spring 2025. Denver recorded 63 overdose deaths in March, followed by 58 in April and another 63 in May—an average of two fatalities every day for three consecutive months. March and May tied for the worst months on record for fatal overdoses in the city.

Dr. Sterling McLaren, chief medical examiner for Denver, identified a consistent pattern among the deceased: most had both fentanyl and methamphetamine in their systems. This drug combination, sometimes called "speedballing" in its modern form, creates a dangerous physiological tension. Fentanyl, a potent opioid, depresses breathing and can rapidly cause fatal respiratory arrest. Methamphetamine, a powerful stimulant, raises heart rate and blood pressure while masking some of fentanyl's sedating effects—potentially leading users to consume more opioids than their bodies can tolerate.

"The combination creates a perfect storm," explained Dr. McLaren in reviewing the autopsy data. "The stimulant keeps people awake and mobile, but it doesn't protect against the respiratory depression caused by the opioid. When the stimulant effects wear off, the full brunt of the opioid hits."

Regional Patterns

Colorado was not alone in bucking the national trend. New Mexico saw overdose deaths rise approximately 21%, while Arizona recorded a 17% increase. Other Western states including Nevada and Utah also reported smaller upticks, though their data remains preliminary.

Public health officials are still working to understand why this regional divergence emerged. Several hypotheses have emerged:

Drug supply dynamics may play a central role. The Western United States has historically had different illicit drug distribution networks than the East Coast and Midwest, with Mexican trafficking organizations maintaining particularly strong presence along the Southwest border and throughout mountain West states. Changes in precursor chemical availability, manufacturing techniques, or trafficking patterns could be affecting drug potency and composition in ways that differ from other regions.

Harm reduction infrastructure varies considerably across states. While Colorado has invested in naloxone distribution and medication-assisted treatment programs, the scale and reach of these services may not match the intensity of need in certain communities. Rural areas of Colorado face particular challenges, with treatment deserts spanning vast geographic areas and limited public transportation connecting residents to services.

Housing instability and economic pressures have intensified in Colorado's Front Range cities, where rapid population growth has strained affordable housing stock. People experiencing homelessness face dramatically elevated overdose risks, with limited access to private spaces where they might use drugs with others present who could intervene in case of overdose.

The National Context

The national decline in overdose deaths represents genuine progress in public health efforts. Expanded naloxone availability, increased access to medication-assisted treatment for opioid use disorder, and growing awareness of harm reduction principles have all contributed to saving lives.

Yet the 70,000 deaths recorded in 2025—while improved from the peak of roughly 110,000 in 2022—still represent a crisis of historic proportions. For context, annual overdose deaths now exceed the total American military fatalities during the entire Vietnam War. Each statistic represents a person: someone's child, parent, friend, or neighbor.

The emergence of powerful synthetic opioids has fundamentally changed the nature of the crisis. Fentanyl, which is roughly 50 times more potent than heroin, now contaminates much of the illicit drug supply—not just opioids, but increasingly stimulants like cocaine and methamphetamine as well. Users may have no awareness that their drugs contain fentanyl, and the margin between a dose that produces euphoria and one that causes death has narrowed to a sliver.

What Colorado Is Doing

Denver has invested in connecting people to healthcare and harm reduction efforts, including offering clean needles and naloxone to people who use drugs. The city has also expanded access to medication-assisted treatment through mobile health units and partnerships with community organizations.

Dr. Leslie Arnaiz, who directs overdose prevention efforts for Denver's public health department, emphasizes the importance of relationships alongside supplies. "People get scared when they see public drug use, and compassion is running short," she noted. "But relationships, along with naloxone, are some of the best tools to prevent more deaths."

Colorado's legislature has taken steps to address the crisis through policy measures, including funding for treatment capacity expansion and measures to reduce barriers to medication-assisted treatment. The state has also received millions in opioid settlement funds from litigation against pharmaceutical manufacturers, though the distribution and deployment of these resources remains an ongoing process.

Looking Forward

The divergence between Colorado's rising deaths and the national decline raises important questions about the equity of crisis response. Are certain regions being left behind as prevention resources concentrate in areas that have already seen success? Are drug supply dynamics evolving in ways that require tailored regional responses?

For people struggling with opioid addiction, the data underscores a critical reality: the drugs circulating in 2025 are unpredictable and potentially lethal. Fentanyl test strips, while not foolproof, can provide some information about drug composition. Naloxone remains a life-saving tool that can reverse opioid overdoses if administered promptly. And medications like buprenorphine and methadone, which reduce cravings and block the effects of other opioids, offer pathways to stability for those ready to engage with treatment.

The spring 2025 spike in Denver may prove to be an anomaly, or it may signal emerging challenges that other communities will soon face. Either way, the data makes clear that the overdose crisis continues to evolve—and that sustained attention, resources, and compassion remain essential to turning the tide.